The suzetrigine, which only acts on pain neurons, is the first innovation in analgesia in the last 20 years. "It stands out ...

The percentage of patients receiving medication for opioid use disorder in federally qualified health centers increased from 2017 to 2023.

A new study led by researchers at the Harvard Pilgrim Health Care Institute found that a 2019 Medicare opioid safety policy showed initial reductions in opioid prescribing to high-risk populations.

Now a third option is available after the U.S. Food and Drug Administration last week approved Vertex Pharmaceuticals’ ...

Journavx works by intercepting pain signals before they reach the spinal cord, rather than acting directly ... as reducing how long patients stay in hospitals, or curbing opioid addiction ...

especially for those who have health issues that can keep them from being accepted by a long-term care plan. 1. Short-term care insurance plans: These policies have a simple health questionnaire ...

Research shows opioids and medical marijuana offer moderate ... another treatment option," Dr. Jacqueline Corrigan-Curay, acting director of the FDA's Center for Drug Evaluation and Research ...

"Today's approval is an important public health milestone in acute pain management,” said Dr. Jacqueline Corrigan-Curay, acting director of the FDA's Center for Drug Evaluation and Research. "A new ...

The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to ...